JPH0788294B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JPH0788294B2 JPH0788294B2 JP62046544A JP4654487A JPH0788294B2 JP H0788294 B2 JPH0788294 B2 JP H0788294B2 JP 62046544 A JP62046544 A JP 62046544A JP 4654487 A JP4654487 A JP 4654487A JP H0788294 B2 JPH0788294 B2 JP H0788294B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- skin
- acid
- weight
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 22
- 239000002253 acid Substances 0.000 claims description 16
- 239000000287 crude extract Substances 0.000 claims description 8
- 150000003904 phospholipids Chemical class 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- -1 ether lipid Chemical class 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 4
- 208000001840 Dandruff Diseases 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 231100000245 skin permeability Toxicity 0.000 description 4
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 3
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000011928 denatured alcohol Substances 0.000 description 3
- FRKBLBQTSTUKOV-UHFFFAOYSA-N diphosphatidyl glycerol Natural products OP(O)(=O)OCC(OP(O)(O)=O)COP(O)(O)=O FRKBLBQTSTUKOV-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 150000003905 phosphatidylinositols Chemical class 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 229940083466 soybean lecithin Drugs 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000002327 glycerophospholipids Chemical class 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001131629 Lancea Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- IKFVJCMZZBWMML-UHFFFAOYSA-N randioside Natural products COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C3C1C=CC3=O IKFVJCMZZBWMML-UHFFFAOYSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 発明の分野 本発明は、皮膚細胞機能を活性化し、皮膚の保護および
美化に顕著な効果を発揮する、有効成分の皮膚浸透性に
優れたべたつきの少ない化粧料に関する。Description: FIELD OF THE INVENTION The present invention relates to a cosmetic composition which activates skin cell functions and exerts a remarkable effect on skin protection and beautification, which is excellent in skin penetration of an active ingredient and has low stickiness.
発明の背景 従来より、ランジウムドメスチカムジャックバーデュー
クまたはランジウムドメスチカムジャックバーランサの
果皮より得られた抽出物およびその特定の成分が5α−
リダクターゼの活性を阻害し、男性ホルモンが関与する
男性型脱毛症、尋常性座瘡、脂漏、フケ症等の疾患の予
防および治療に効果のあることが知られている(特開昭
60−243020号参照)。BACKGROUND OF THE INVENTION Conventionally, an extract obtained from the skin of Randum domesticus camber barduke or Randium domesticus camouflage bar balancer and its specific component are 5α-
It is known that it inhibits the activity of reductase and is effective for the prevention and treatment of androgenetic alopecia, acne vulgaris, seborrhea, dandruff and the like, which are involved in male hormones (Japanese Patent Laid-Open Publication No. Sho.
See 60-243020).
このような効果は、5α−リダクターゼ活性の阻害によ
り皮膚細胞のエネルギー産生が増大し細胞が活性化する
ことによって生じるものである。したがって、該抽出物
等を基剤として配合すれば、男性ホルモンが関与する種
々の皮膚疾患を予防および治療することにより生き生き
した肌を再生、維持するのに効果のある化粧料が得られ
るものと期待される。Such an effect is caused by activation of cells by increasing energy production of skin cells due to inhibition of 5α-reductase activity. Therefore, if the extract or the like is added as a base, a cosmetic effective for regenerating and maintaining live skin by preventing and treating various skin diseases involving male hormones can be obtained. Be expected.
しかしながら、該抽出物等を基剤として配合した化粧料
を肌に塗布した場合、非常にべたつき易く、さっぱり感
が要求される化粧料に用いるには不適当であり、また、
該抽出物等の皮膚浸透性が不充分であって満足のいく効
果を発揮するものが得られていない。そこで、皮膚塗布
時のべたつき感を緩和し、かつ、該抽出物等の皮膚浸透
性を高めるような処方が要望されている。However, when a cosmetic containing the extract or the like as a base is applied to the skin, it is extremely sticky and unsuitable for use in a cosmetic requiring a refreshing feeling.
The skin permeability of the extract or the like is insufficient, and no one showing a satisfactory effect has been obtained. Therefore, there is a demand for a formulation that alleviates the sticky feeling upon application to the skin and enhances the skin permeability of the extract or the like.
本発明者らは、以上の欠点を改良し、塗布時のべたつき
感がなく、かつ、有効成分の皮膚浸透性を高めた皮膚の
保護および美化に優れた効果を発揮する化粧料を得るべ
く鋭意検討を行なった結果、前記の粗抽出物および/ま
たはその特定の成分をリン脂質と併用することにより、
良好な特性を有する化粧料が得られることを見出だし、
本発明を完成するに至った。The inventors of the present invention are eager to obtain a cosmetic that improves the above drawbacks, does not have a sticky feeling upon application, and has excellent skin protection and beautification with enhanced skin penetration of the active ingredient. As a result of the examination, by using the crude extract and / or its specific component in combination with a phospholipid,
It was found that a cosmetic having good characteristics can be obtained,
The present invention has been completed.
発明の開示 本発明は、リン脂質の1種または2種以上を化粧料全量
に対して0.01〜3重量%およびランジウムドメスチカム
ジャックバーデューク(以下、デュークと称する)また
はランジウムドメスチカムジャックバーランサ(以下、
ランサと称する)の果皮より得られた粗抽出物およびそ
の成分であるランジック酸、ランジオサイドおよびそれ
らの誘導体の1種または2種以上をランジック酸として
化粧料全量に対して0.01〜3重量%配合したことを特徴
とする化粧料を提供するものである。DISCLOSURE OF THE INVENTION The present invention provides one or two or more phospholipids in an amount of 0.01 to 3% by weight based on the total amount of cosmetics, and Randium domesticus Jack Burduke (hereinafter referred to as Duke) or Randium domesticus camouflage. Jack Barlancer (hereinafter,
0.01 to 3% by weight based on the total amount of cosmetics of crude extract obtained from pericarp of lancea) and one or more of its components, randic acid, randioside and derivatives thereof. The present invention provides a cosmetic characterized by being blended.
本発明の化粧料は、塗布時にべたつき感がなく、有効成
分の皮膚浸透性に優れており、皮膚に塗布することによ
り皮膚細胞機能が活性化し、皮膚の保護および美化に顕
著な効果を発揮する。The cosmetic of the present invention does not have a sticky feeling when applied, and has excellent skin permeability of the active ingredient. When applied to the skin, the skin cell function is activated to exert a remarkable effect on protection and beautification of the skin. .
本発明の化粧料に配合するリン脂質は、細胞の種々の膜
系を構成する主要な脂質であり、血清脂質や卵黄等にも
含有されており、その構成成分よりグリセロリン脂質と
スフィンゴリン脂質に分類される。グリセロリン脂質と
してはホスファチジルコリン、ホスファチジルエタノー
ルアミン、ホスファチジルセリン、ホスファチジルイノ
シトール、ホスファチジルグリセロール、ジホスファチ
ジルグリセロール、プラスマローゲン、エーテル脂質な
どが挙げられ、スフィンゴリン脂質としてはスフィンゴ
ミエリンなどが挙げられる。前記リン脂質は、化粧料全
量に対して0.01〜3重量%、好ましくは、0.05〜1重量
%配合される。配合量が0.01重量%より少ないと充分な
効果が得られず、また、3重量%より多いと基剤への溶
解が困難になる場合がある。The phospholipid to be added to the cosmetic of the present invention is a major lipid that constitutes various membrane systems of cells, and is also contained in serum lipids, egg yolk, etc., and its constituent components lead to glycerophospholipids and sphingophospholipids. being classified. Examples of the glycerophospholipid include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, diphosphatidylglycerol, plasmalogen, and ether lipid, and examples of the sphingolipid include sphingomyelin. The phospholipid is blended in an amount of 0.01 to 3% by weight, preferably 0.05 to 1% by weight, based on the total amount of the cosmetic. If the blending amount is less than 0.01% by weight, a sufficient effect cannot be obtained, and if it is more than 3% by weight, it may be difficult to dissolve in the base material.
本発明の化粧料に配合するデュークまたはランサの果皮
より得られる粗抽出物、ランジック酸およびランジオサ
イドの抽出、分離および精製法ならびにその構造に関し
ては公知であり(例えば、特開昭60−243020号参照)、
商業的に入手することができる。誘導体としては、ラン
ジック酸の塩(例えば、ナトリウム塩、二ナトリウム塩
など)エステル(例えば、炭素数2〜12のモルアルキル
エステル、炭素数2〜12のジアルキルエステルなど)、
ランジオサイドの塩(例えば、ナトリウム塩、カリウム
塩など)、エステル(例えば、炭素数2〜12のモルアル
キルエステルなど)などが挙げられ、常法により製造す
ることができる。前記の粗抽出物、ランジック酸、ラン
ジオサイドおよびそれらの誘導体は、ランジック酸とし
て化粧料全量に対して0.01〜3重量%、好ましくは、0.
05〜1重量%配合される。配合量が0.01重量%より少な
いと充分な薬効が得られず、また、3重量%より多いと
基剤への溶解が困難になる場合がある。The crude extract obtained from the skin of Duke or Lansa, which is incorporated into the cosmetic of the present invention, the method for extracting, separating and purifying randic acid and landioside and the structure thereof are known (for example, JP-A-60-243020). No.),
It can be obtained commercially. As the derivative, a salt of randic acid (for example, sodium salt, disodium salt, etc.) ester (for example, a mole alkyl ester having 2 to 12 carbon atoms, a dialkyl ester having 2 to 12 carbon atoms),
Examples thereof include salts of landioside (for example, sodium salt, potassium salt, etc.), esters (for example, mol alkyl ester having 2 to 12 carbon atoms, etc.), and can be produced by a conventional method. The crude extract, landic acid, landioside and their derivatives are 0.01 to 3% by weight, preferably 0.
It is blended from 05 to 1% by weight. If the blending amount is less than 0.01% by weight, a sufficient drug effect cannot be obtained, and if it is more than 3% by weight, it may be difficult to dissolve it in the base.
さらに、本発明の化粧料には、必要に応じて適当な多価
アルコール、油性成分、紫外線吸収剤、抗酸化剤、防腐
剤、殺菌剤、薬剤、香料、色素等をその特性を損なわな
い範囲で添加してよい。Further, in the cosmetic of the present invention, a suitable polyhydric alcohol, an oily component, an ultraviolet absorber, an antioxidant, an antiseptic, a bactericide, a drug, a fragrance, a dye, etc. are added in a range not impairing the properties thereof, if necessary. May be added in.
本発明の化粧料は常法に従って製造することができ、溶
液系、乳化系、粉末分散系にて化粧水、乳液、クリー
ム、パック、ファンデーション等の基礎化粧品、メーキ
ャップ等およびシャンプー、ヘアートニック、ヘアーリ
キッド、ヘアートリートメント、ヘアースプレー等の頭
髪化粧用等の通常の剤形とすることができる。The cosmetics of the present invention can be produced according to a conventional method, such as solution system, emulsion system, powder dispersion system, basic cosmetics such as lotion, emulsion, cream, pack, foundation, make-up and shampoo, hair art, hair. It may be a usual dosage form for hair makeup such as liquid, hair treatment, and hair spray.
実施例 つぎに実施例を挙げて本発明をさらに詳しく説明する。EXAMPLES Next, the present invention will be described in more detail with reference to Examples.
実施例1 化粧水 室温にて、前記BをAに加え、混合して可溶化した後
過して化粧水を製造した。Example 1 lotion At room temperature, B was added to A, mixed and solubilized, and then filtered to produce a lotion.
実施例2 ヘアートリートメント 撹拌下、Aを75℃に加熱して溶解した。得られた溶液に
約75℃に加熱したBを加え、充分に撹拌した後冷却して
ヘアートリートメントを製造した。Example 2 Hair Treatment With stirring, A was heated to 75 ° C. and dissolved. B heated to about 75 ° C. was added to the obtained solution, and the mixture was sufficiently stirred and then cooled to produce a hair treatment.
実施例3 洗顔クリーム 撹拌下、成分Aを約75℃に加熱して溶解した。得られた
溶液に約75℃に加熱した成分Bを撹拌しながら加え、充
分に混合した後冷却して洗顔クリームを製造した。Example 3 Face-wash cream With stirring, Component A was heated to about 75 ° C. and dissolved. Component B heated to about 75 ° C. was added to the obtained solution with stirring, thoroughly mixed and then cooled to produce a face cleansing cream.
実施例4 油性クリーム 撹拌下、成分Aを約75℃に加熱して溶解した。得られた
溶液に約75℃に加熱した成分Bを撹拌しながら加え、充
分に混合した後冷却して油性クリームを製造した。Example 4 Oily cream With stirring, Component A was heated to about 75 ° C. and dissolved. Component B heated to about 75 ° C. was added to the obtained solution with stirring, mixed well and cooled to produce an oily cream.
実施例5 シャンプー 成分 重量% ランジック酸 1.0 水添レシチン 3.0 アルキル硫酸トリエタノールアミン10.0 ヤシ油脂肪酸ジエタノールアミド 5.0 プロピレングリコール 5.0 ジステアリン酸エチレングリコール 2.0 尿素 0.5 防腐剤および香料 微量 イオン交換水 適量 以上の処方により、常法に従ってシャンプーを製造し
た。Example 5 Shampoo Ingredients wt% Langic acid 1.0 Hydrogenated lecithin 3.0 Alkylsulfate triethanolamine 10.0 Coconut oil fatty acid diethanolamide 5.0 Propylene glycol 5.0 Ethylene glycol distearate 2.0 Urea 0.5 Preservative and fragrance Trace amount of ion-exchanged water Shampoo was manufactured according to a conventional method.
実施例6 リンス 成 分 重量% デューク抽出物 3.0 ホスファチジルエタノールアミン 0.3 ホスファチジルグリセロール 0.3 ジホスファチジルグリセロール 0.3 プラスマローゲン 0.1 プロピレングリコール 4.0 流動パラフィン 3.0 モノオレイン酸ソルビタン 2.0 塩化セチルトリメチルアンモニウム 1.5 セタノール 1.0 ポリビニルピロリドン 1.0 モノオレイン酸ポリオキシエチレン (20E.O.)ソルビタン 0.2 防腐剤および香料 微量 イオン交換水 適量 以上の処方により、常法に従ってリンスを製造した。Example 6 Rinsing component wt% Duke extract 3.0 Phosphatidylethanolamine 0.3 Phosphatidylglycerol 0.3 Diphosphatidylglycerol 0.3 Plasmalogen 0.1 Propylene glycol 4.0 Liquid paraffin 3.0 Sorbitan monooleate 2.0 Cetyltrimethylammonium chloride 1.5 Cetanol 1.0 Polyvinylpyrrolidone 1.0 Monooleic acid Polyoxyethylene (20E.O.) sorbitan 0.2 Preservative and fragrance Trace amount of ion-exchanged water An appropriate amount of the above formulation was used to prepare a rinse according to a conventional method.
実施例7 石けん 成 分 重量% ランジック酸 3.0 卵黄レシチン 3.0 石けん用素地 50.0 変性アルコール 20.0 濃グリセリン 5.0 グリチルリチン酸ジカリウム 0.2 エデト酸二ナトリウム 0.02 香料 1.0 イオン交換水 適量 以上の処方により、常法に従って石けんを製造した。Example 7 Soap constituent% by weight Langic acid 3.0 Egg yolk lecithin 3.0 Soap substrate 50.0 Denatured alcohol 20.0 Concentrated glycerin 5.0 Dipotassium glycyrrhizinate 0.2 Disodium edetate 0.02 Perfume 1.0 Ion-exchanged water Producing soap according to a conventional method according to the above formulation. did.
実施例8 スカルプローション 成 分 重量% デューク抽出物 10.0 大豆レシチン 0.5 95゜ブルシン変性アルコール 60.0 濃グリセリン 5.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 香料 0.5 イオン交換水 適量 以上の処方により、常法に従ってスカルプローションを
製造した。Example 8 Scalprotion component wt% Duke extract 10.0 Soy lecithin 0.5 95 ° Brucine denatured alcohol 60.0 Concentrated glycerin 5.0 Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0 Fragrance 0.5 Ion-exchanged water Skull protions were manufactured according to the method.
実施例9 ヘアートニック 成 分 重量% ランジック酸 0.3 ホスファチジルセリン 0.1 ホスファチジルグリセロール 0.1 99%変性アルコール 15.0 POE・POPセチルエーテル 3.0 POE・POPデシルテトラデシルエーテル 1.0 l−メントール 0.5 香料 0.5 イオン交換水 適量 以上の処方により、常法に従ってヘアートニックを製造
した。Example 9 Hairnic component weight% Landic acid 0.3 Phosphatidylserine 0.1 Phosphatidylglycerol 0.1 99% Denatured alcohol 15.0 POE / POP cetyl ether 3.0 POE / POP decyl tetradecyl ether 1.0 l-menthol 0.5 Fragrance 0.5 Ion-exchanged water Was manufactured according to a conventional method.
実施例10 モイスチャーパック 成 分 重量% デューク抽出物 5.0 水添レシチン 1.0 ミリスチン酸イソプロピル 15.0 流動パラフィン 10.0 ステアリン酸 6.0 マルチトール 5.0 プロピレングリコール 5.0 親油型モノステアリン酸グリセリン 3.0 ステアリルアルコールポリオキシエチレン (20E.O.)ステアリルアルコール 3.0 モノステアリン酸ポリオキシソルビタン(20E.O.) 2.0 防腐剤および香料 微量 イオン交換水 適量 以上の処方により、常法に従ってモイスチャーパックを
製造した。Example 10 Moisture pack component% by weight Duke extract 5.0 Hydrogenated lecithin 1.0 Isopropyl myristate 15.0 Liquid paraffin 10.0 Stearic acid 6.0 Maltitol 5.0 Propylene glycol 5.0 Glycerin monostearate 3.0 Stearyl alcohol Polyoxyethylene (20E.O .) Stearyl alcohol 3.0 Polyoxysorbitan monostearate (20E.O.) 2.0 Preservative and perfume Trace amount of ion-exchanged water An appropriate amount of the above formulation was used to produce a moisture pack according to a conventional method.
実施例11 モイスチャークリーム 成 分 重量% ランジック酸 0.5 ホスファチジルイノシトール 0.1 ジホスファチジルグリセロール 0.05 パルミチン酸イソプロピル 4.0 ステアリン酸 4.0 スクワラン 3.0 プロピレングリコール 3.0 1,3−ブチレングリコール 3.0 メチルポリシロキサン 2.0 親油型モノステアリン酸グリセリン 1.0 ミリスチン酸ミリスチル 1.0 防腐剤および香料 微量 イオン交換水 適量 以上の処方により、常法に従ってモイスチャークリーム
を製造した。Example 11 Moisture Cream Composition Weight% Landic Acid 0.5 Phosphatidylinositol 0.1 Diphosphatidylglycerol 0.05 Isopropyl palmitate 4.0 Stearic acid 4.0 Squalane 3.0 Propylene glycol 3.0 1,3-Butylene glycol 3.0 Methylpolysiloxane 2.0 Glycerin monostearate 1.0 Myristyl myristate 1.0 Preservative and fragrance Trace amount of ion-exchanged water An appropriate amount of the above formulation was used to produce a moisture cream according to a conventional method.
実施例12 ヘアートリートメント 成分Aおよび成分Bをそれぞれ約75℃にて均一に溶解し
た。ついで、撹拌しながら成分Bを成分Aに加えた後、
冷却してヘアートリートメントを製造した。Example 12 Hair Treatment Component A and component B were each uniformly dissolved at about 75 ° C. Then, after adding component B to component A with stirring,
Cooled to produce a hair treatment.
実施例13 ポマード 成 分 重量% ランジック酸 0.5 大豆レシチン 1.0 硬化ヒマシ油 49.0 木ロウ 19.3 流動パラフィン 15.0 ワセリン 10.0 オリーブ油 5.0 ソルビトール 0.2 以上の成分を約75℃にて溶解し、ついで、撹拌しながら
冷却してポマードを製造した。Example 13 Pomade Component Weight% Landic Acid 0.5 Soybean Lecithin 1.0 Hydrogenated Castor Oil 49.0 Wood Wax 19.3 Liquid Paraffin 15.0 Vaseline 10.0 Olive Oil 5.0 Sorbitol 0.2 The above ingredients are dissolved at about 75 ° C., then cooled with stirring. Produced Pomade.
実施例14 ヘアークリーム 成分Aおよび成分Bをそれぞれ約80℃にて均一に溶解し
た。ついで、撹拌しながら成分Aを成分Bに加えた後、
冷却してヘアークリームを製造した。Example 14 Hair cream Component A and component B were each uniformly dissolved at about 80 ° C. Then, after adding component A to component B with stirring,
Cooled to produce a hair cream.
実施例15 液状整髪料 成 分 重量% 20%デューク果皮粗抽出物(エタノール溶液) 5.0 スフィンゴミエリン 2.0 エタノール 50.0 ポリオキシプロピレンブチルエーテル 10.0 グリセリン 2.0 ヒアルロン酸 0.01 香料 0.3 精製水 適量 以上の成分により、常法に従って液状整髪料を製造し
た。Example 15 Liquid hair styling ingredient% by weight 20% Duke skin rough extract (ethanol solution) 5.0 Sphingomyelin 2.0 Ethanol 50.0 Polyoxypropylene butyl ether 10.0 Glycerin 2.0 Hyaluronic acid 0.01 Fragrance 0.3 Purified water A liquid hair styling product was produced.
実施例16 化粧水 成 分 重量% ランジック酸ナトリウム 0.1 ホスファチジルセリン 0.1 エチルアルコール 20.0 グリセリン 3.0 ペンタエリスリトール 2.0 ポリオキシエチレン硬化ヒマシ油 0.5 乳酸 0.3 香料 0.1 防腐剤 微量 精製水 適量 以上の成分により、常法に従って化粧水を製造した。Example 16 Skin lotion component% by weight Sodium radicate 0.1 Phosphatidylserine 0.1 Ethyl alcohol 20.0 Glycerin 3.0 Pentaerythritol 2.0 Polyoxyethylene hydrogenated castor oil 0.5 Lactic acid 0.3 Fragrance 0.1 Preservative Trace amount of purified water Water was produced.
実施例17 乳液 成分Aおよび成分Bをそれぞれ約70℃にて均一に溶解し
た。ついで、撹拌しながら成分Aを成分Bに加えた後、
冷却し、成分Cを加えて乳液を製造した。Example 17 Emulsion Component A and component B were uniformly dissolved at about 70 ° C. Then, after adding component A to component B with stirring,
After cooling, component C was added to produce an emulsion.
実施例18 制汗剤 成分Aを均一に分散し、耐圧缶に入れた後密閉し、成分
Bを充填して制汗剤を製造した。Example 18 Antiperspirant Ingredient A was uniformly dispersed, placed in a pressure-resistant can and then sealed, and ingredient B was filled to produce an antiperspirant.
実施例19 アフターシェーブローション 成 分 重量% 20%デューク果皮粗抽出物(エタノール溶液) 1.5 卵黄レシチン 0.4 エタノール 40.0 1,3−ブチレングリコール 1.0 ポリオキシエチレンセチルエーテル 0.6 ポリオキシエチレンシリコン誘導体 0.1 ヒアルロン酸ナトリウム 0.05 香料 0.3 精製水 適量 以上の成分により、常法に従ってアフターシューブロー
ションを製造した。Example 19 After-shave lotion composition% by weight 20% Duke skin crude extract (ethanol solution) 1.5 egg yolk lecithin 0.4 ethanol 40.0 1,3-butylene glycol 1.0 polyoxyethylene cetyl ether 0.6 polyoxyethylene silicon derivative 0.1 sodium hyaluronate 0.05 fragrance 0.3 Purified water An aftershoe lotion was produced by an ordinary method using the above components in an appropriate amount.
実施例20 日焼け止め化粧料 成分Aおよび成分Bをそれぞれ約75℃にて均一に溶解し
た。ついで、撹拌しながら成分Aを成分Bに加えた後、
冷却して日焼け止め化粧料を製造した。Example 20 Sunscreen cosmetics Component A and component B were each uniformly dissolved at about 75 ° C. Then, after adding component A to component B with stirring,
After cooling, a sunscreen cosmetic was manufactured.
実施例21 養毛料 成 分 重量% デューク抽出物 1.0 ホスファチジルイノシトール 1.0 エタノール 50.0 ポリオキシエチレン硬化ヒマシ油 2.0 ピロリドンカルボン酸ナトリウム 1.0 センブリ抽出エキス 0.2 ヒノキチオール 0.1 塩酸ピリドキシン 0.1 酢酸d1−α−トコフェロール 0.01 香料 0.3 精製水 適量 以上の成分を均一に撹拌溶解して養毛料を製造した。Example 21 Hair nourishment component% by weight Duke extract 1.0 Phosphatidylinositol 1.0 Ethanol 50.0 Polyoxyethylene hydrogenated castor oil 2.0 Sodium pyrrolidonecarboxylate 1.0 Assemblage extract 0.2 Hinokitiol 0.1 Pyridoxine hydrochloride 0.1 Acetate d1-α-tocopherol 0.01 Perfume 0.3 Purified water An appropriate amount of the above ingredients was dissolved by stirring uniformly to produce a hair nourishing agent.
つぎに、大豆レシチンを配合しない以外、前記実施例1
と同様にして対照例1(化粧水)を製造した。ついで、
同様な肌質を持つ20名の女性パネル員を2群に分け、1
群に実施例1の化粧水、他の1群に対照例1の化粧水を
2カ月間、1日に2回顔に塗布させ、2カ月後に使用感
および皮膚機能改善度を官能評価にて自己申告させた。
結果を第1表に示す。表中の数値は、該当する評価をし
たパネル員の人数である。Next, except that soybean lecithin was not added, the above-mentioned Example 1 was used.
Comparative Example 1 (lotion) was produced in the same manner as in. Then,
Divide 20 female panel members with similar skin quality into 2 groups, 1
The lotion of Example 1 was applied to one group, and the lotion of Control Example 1 was applied to the other group twice a day for 2 months, and after 2 months, the feeling of use and the degree of skin function improvement were evaluated by sensory evaluation. I let myself declare it.
The results are shown in Table 1. The numbers in the table are the number of panel members who made the corresponding evaluations.
第1表に示したように、リン脂質の1種である大豆レシ
チンを併用することにより、ランジック酸配合に起因す
るべたつき感の緩和およびランジック酸の皮膚浸透性増
加に起因する皮膚機能の改善に著しい効果が認められ
た。 As shown in Table 1, by using soybean lecithin, which is one of phospholipids, in combination with landic acid, it is possible to reduce the stickiness and improve the skin function caused by the increased skin permeability of radisic acid. A remarkable effect was recognized.
さらに、卵黄レシチンを配合しない以外、前記実施例2
と同様にして対照例2(ヘアートリートメント)を製造
した。ついで、フケ症を伴う男性型脱毛症の男性パネル
員30名を2群に分け、1群に実施例2のヘアートリート
メントを、他の1群に対照例2のヘアートリートメント
を3カ月間、1日に2回頭皮に塗布、マッサージさせ、
3カ月後に使用感、抜毛およびフケの発生を評価させ
た。結果を第2表に示す。表中の数値は、該当する評価
をしたパネル員の人数である。Furthermore, except that the egg yolk lecithin was not added,
Comparative Example 2 (hair treatment) was produced in the same manner as in. Then, 30 male panel members with androgenetic alopecia associated with dandruff were divided into two groups, one group was treated with the hair treatment of Example 2 and the other group was treated with the hair treatment of Control Example 2 for 3 months. Apply to the scalp twice a day, massage it,
After 3 months, the feeling of use, hair loss and the occurrence of dandruff were evaluated. The results are shown in Table 2. The numbers in the table are the number of panel members who made the corresponding evaluations.
第2表に示したように、リン脂質の1種である卵黄レシ
チンを併用することにより、ランジック酸およびデュー
ク果皮粗抽出物配合に起因するべたつき感の緩和ならび
にランジック酸およびデューク粗抽出物の皮膚浸透性増
加に起因する抜毛の減少およびフケ症状の改善に著しい
効果が認められた。 As shown in Table 2, the combined use of egg yolk lecithin, which is one of the phospholipids, alleviates the sticky feeling caused by the combination of randic acid and Duke's skin crude extract, and the skin of randic acid and Duke's crude extract. A remarkable effect was observed in reducing hair loss and improving dandruff symptoms due to increased permeability.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 野河 泰博 大阪府高槻市殿町13−10−107 (56)参考文献 特開 昭60−243020(JP,A) 特開 昭60−94903(JP,A) 特開 昭55−47608(JP,A) 特開 昭57−179109(JP,A) ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Yasuhiro Nogawa 13-10-107 Tonomachi, Takatsuki City, Osaka (56) References JP-A-60-243020 (JP, A) JP-A-60-94903 (JP, A) JP-A-55-47608 (JP, A) JP-A-57-179109 (JP, A)
Claims (1)
量に対して0.01〜3重量%およびランジウムドメスチカ
ムジャックバーデュークまたはランジウムドメスチカム
ジャックバーランサの果皮より得られた粗抽出物、その
成分であるランジック酸、ランジオサイドおよびそれら
の誘導体の1種または2種以上をランジック酸として化
粧料全量に対して0.01〜3重量%配合したことを特徴と
する化粧料。1. One or more phospholipids, obtained in an amount of 0.01 to 3% by weight based on the total amount of cosmetics, and from the skin of Randum domesticus jack barduke or Randium domesticus jack bar balancer. A cosmetic, comprising 0.01 to 3% by weight of the crude extract, one or more of its components, radinic acid, landioside and derivatives thereof, as radisic acid with respect to the total amount of the cosmetic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62046544A JPH0788294B2 (en) | 1987-02-26 | 1987-02-26 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62046544A JPH0788294B2 (en) | 1987-02-26 | 1987-02-26 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63211208A JPS63211208A (en) | 1988-09-02 |
| JPH0788294B2 true JPH0788294B2 (en) | 1995-09-27 |
Family
ID=12750248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62046544A Expired - Lifetime JPH0788294B2 (en) | 1987-02-26 | 1987-02-26 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0788294B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3629278B2 (en) * | 1992-12-12 | 2005-03-16 | 太陽化学株式会社 | Cosmetics |
| JPH0812529A (en) * | 1994-06-23 | 1996-01-16 | Riken Health Kk | Transparent hair-raising agent |
| JP5063324B2 (en) * | 2007-12-14 | 2012-10-31 | 株式会社 資生堂 | Wax composition |
| JP2015127319A (en) * | 2013-11-29 | 2015-07-09 | 花王株式会社 | Skin external preparation |
-
1987
- 1987-02-26 JP JP62046544A patent/JPH0788294B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63211208A (en) | 1988-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10513188A (en) | Composition for makeup makeup | |
| JPH01319412A (en) | Natural component-containing hair treatment preparation | |
| JPS6341363B2 (en) | ||
| DE69311541T2 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING THE DEACYLATED GLYCEROPHOSPHOLIPIDES | |
| JP3432848B2 (en) | Hair restorer | |
| JPS6115809A (en) | Cell activator | |
| JP3513872B2 (en) | External preparation for skin | |
| CA2365660A1 (en) | Treatment for skin | |
| JPH08133952A (en) | Skin preparation for external use | |
| JPS60116618A (en) | Cosmetic | |
| JPH0745387B2 (en) | Hair growth and hair growth promoter | |
| JPH0788294B2 (en) | Cosmetics | |
| JP2694756B2 (en) | Cosmetics containing divalent and trivalent iron salts | |
| JP3568983B2 (en) | Hair restorer | |
| JPS6256411A (en) | Beautifying agent | |
| JP3659793B2 (en) | Skin condition improvement makeup cosmetics | |
| JPH08133948A (en) | Skin preparation for external use | |
| JPH08133950A (en) | Skin preparation for external use | |
| JP2855274B2 (en) | Hair restoration | |
| JP2620770B2 (en) | External preparation for skin | |
| JP3205601B2 (en) | Hair restorer | |
| JPH0235721B2 (en) | ||
| JP2522803B2 (en) | Cosmetics | |
| JP2000191499A (en) | Moisturizing skin cosmetics | |
| JP2001031554A (en) | Preparation for external use for skin |